Loss of SIRT4 appears to be a result of mammalian target of rapamycin complex 1 (mTORC1), a complex consisting of mTOR, Raptor, and mLST8 that is dysregulated in human cancers and activated under nutrient-rich conditions [90]. This evidence concerns the gene SIRT4 and cancer.